Indications
Therapeutic Asset Ratings
6,302 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Byon5667
Breast Cancer
Byondis B.V.
P1/2
CC
(46)
Cabozantinib
Esophageal Adenocarcinoma
Anwaar Saeed
P1/2
CC
(46)
Carbidopa
Orthostatic Hypotension
Julien Bally
P1/2
CC
(46)
cd19-ucart
Childhood Acute Lymphoblastic Leukemia
University Hospital Tuebingen
P1/2
CC
(46)
CD47/SIRPA-BLOCKING AGENT ALX148
Composite Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(46)
CD47/SIRPA-BLOCKING AGENT ALX148
Plasma Cell Myeloma
Sanofi
P1/2
CC
(46)
CD47/SIRPA-BLOCKING AGENT ALX148
High Grade B-Cell Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(46)
CD47/SIRPA-BLOCKING AGENT ALX148
Mantle Cell Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(46)
CD47/SIRPA-BLOCKING AGENT ALX148
Primary Mediastinal Large B-Cell Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(46)
Cetuximab
Digestive System Cancer
Revolution Medicines, Inc.
P1/2
CC
(46)
Cetuximab
Histiocytic And Dendritic Cell Neoplasm
Institut de Recherches Internationales Servier
P1/2
CC
(46)
Cmtx-101
Cystic Fibrosis
Clarametyx Biosciences, Inc.
P1/2
CC
(46)
Cobolimab
Fibrolamellar Hepatocellular Carcinoma
GlaxoSmithKline
P1/2
CC
(46)
Cobolimab
Glioblastoma
GlaxoSmithKline
P1/2
CC
(46)
Cobolimab
Hepatoblastoma
GlaxoSmithKline
P1/2
CC
(46)
Cobolimab
Glioma
GlaxoSmithKline
P1/2
CC
(46)
Copanlisib
Metastatic Prostate Carcinoma
Brown University
P1/2
CC
(46)
Copanlisib
Triple-Negative Breast Carcinoma
National Cancer Institute (NCI)
P1/2
CC
(46)
ctx131
Nonpapillary Renal Cell Carcinoma
CRISPR Therapeutics AG
P1/2
CC
(46)
ctx131
Pancreatic Adenocarcinoma
CRISPR Therapeutics AG
P1/2
CC
(46)
Cypate-Cyclo(Cys-Gly-Arg-Asp-Ser-Pro-Cys)-Lys-Oh (Ls301)
Ductal Breast Carcinoma In Situ
Integro Theranostics
P1/2
CC
(46)
Cypate-Cyclo(Cys-Gly-Arg-Asp-Ser-Pro-Cys)-Lys-Oh (Ls301)
Invasive Ductal Breast Carcinoma
Integro Theranostics
P1/2
CC
(46)
Cypep-1
Breast Cancer
Cytovation AS
P1/2
CC
(46)
Cypep-1
Melanoma
Cytovation AS
P1/2
CC
(46)
Decitabine
Synovial Sarcoma
Roswell Park Cancer Institute
P1/2
CC
(46)
Showing 3176 to 3200 of 6,302 assets
Previous
Page 128 of 253
Next